3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)aniline;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide;5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole

C149H143F12N25O16S2 — CID 159222266

About 3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)aniline;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide;5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole

3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)aniline;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide;5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole (PubChem CID 159222266) has the molecular formula C149H143F12N25O16S2 and a molecular weight of 2832.05 g/mol. Its IUPAC name is 3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)aniline;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide;5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole.

Molecular Properties

• Compound Name: 3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)aniline;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide;5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole
• PubChem CID: 159222266
• Molecular Formula: C149H143F12N25O16S2
• Molecular Weight: 2832.05 g/mol
• Exact Mass: 2830.04
• IUPAC Name: 3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)aniline;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide;5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole
• SMILES: COc1ccc(F)cc1-c1noc(-c2ccc(-c3cccnc3C)c(C)c2)n1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3C)c(C#N)c2)n1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3C)c(N)c2)n1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3C)c(NS(C)(=O)=O)c2)n1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3C)nc2)n1.COc1ccc(F)cc1-c1noc(-c2cnc(N3CCCCC3C)c(C)c2)n1.Cc1cscc1-c1ccc(-c2nc(-c3ccccc3OC(F)(F)F)no2)cc1C(F)(F)F
• InChI: InChI=1S/C22H25FN4O4S.C22H21FN4O2.C22H18FN3O2.C21H12F6N2O2S.2C21H23FN4O2.C20H21FN4O2/c1-14-6-4-5-11-27(14)19-9-7-15(12-18(19)26-32(3,28)29)22-24-21(25-31-22)17-13-16(23)8-10-20(17)30-2;1-14-5-3-4-10-27(14)19-8-6-15(11-16(19)13-24)22-25-21(26-29-22)18-12-17(23)7-9-20(18)28-2;1-13-11-15(6-8-17(13)18-5-4-10-24-14(18)2)22-25-21(26-28-22)19-12-16(23)7-9-20(19)27-3;1-11-9-32-10-15(11)13-7-6-12(8-16(13)20(22,23)24)19-28-18(29-31-19)14-4-2-3-5-17(14)30-21(25,26)27;1-13-10-15(12-23-20(13)26-9-5-4-6-14(26)2)21-24-19(25-28-21)17-11-16(22)7-8-18(17)27-3;1-13-5-3-4-10-26(13)18-8-6-14(11-17(18)23)21-24-20(25-28-21)16-12-15(22)7-9-19(16)27-2;1-13-5-3-4-10-25(13)18-9-6-14(12-22-18)20-23-19(24-27-20)16-11-15(21)7-8-17(16)26-2/h7-10,12-14,26H,4-6,11H2,1-3H3;6-9,11-12,14H,3-5,10H2,1-2H3;4-12H,1-3H3;2-10H,1H3;7-8,10-12,14H,4-6,9H2,1-3H3;6-9,11-13H,3-5,10,23H2,1-2H3;6-9,11-13H,3-5,10H2,1-2H3
• InChIKey: KRVOIWOFRJTWKY-UHFFFAOYSA-N
• XLogP: 35.16
• TPSA: 487.90 Ų
• H-Bond Donors: 2
• H-Bond Acceptors: 41
• Rotatable Bonds: 30
• Heavy Atoms: 204
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2832.05
LogP ≤ 5	35.16
H-Bond Donors ≤ 5	2
H-Bond Acceptors ≤ 10	41

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'aniline', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)aniline;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide;5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole?

The IUPAC name of 3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)aniline;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide;5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole (CID 159222266) is 3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)aniline;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide;5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole.

What is the SMILES notation for 3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)aniline;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide;5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole?

The canonical SMILES for 3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)aniline;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide;5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole is COc1ccc(F)cc1-c1noc(-c2ccc(-c3cccnc3C)c(C)c2)n1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3C)c(C#N)c2)n1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3C)c(N)c2)n1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3C)c(NS(C)(=O)=O)c2)n1.COc1ccc(F)cc1-c1noc(-c2ccc(N3CCCCC3C)nc2)n1.COc1ccc(F)cc1-c1noc(-c2cnc(N3CCCCC3C)c(C)c2)n1.Cc1cscc1-c1ccc(-c2nc(-c3ccccc3OC(F)(F)F)no2)cc1C(F)(F)F.

What is the InChIKey of 3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)aniline;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide;5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole?

The InChIKey is KRVOIWOFRJTWKY-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H25FN4O4S.C22H21FN4O2.C22H18FN3O2.C21H12F6N2O2S.2C21H23FN4O2.C20H21FN4O2/c1-14-6-4-5-11-27(14)19-9-7-15(12-18(19)26-32(3,28)29)22-24-21(25-31-22)17-13-16(23)8-10-20(17)30-2;1-14-5-3-4-10-27(14)19-8-6-15(11-16(19)13-24)22-25-21(26-29-22)18-12-17(23)7-9-20(18)28-2;1-13-11-15(6-8-17(13)18-5-4-10-24-14(18)2)22-25-21(26-28-22)19-12-16(23)7-9-20(19)27-3;1-11-9-32-10-15(11)13-7-6-12(8-16(13)20(22,23)24)19-28-18(29-31-19)14-4-2-3-5-17(14)30-21(25,26)27;1-13-10-15(12-23-20(13)26-9-5-4-6-14(26)2)21-24-19(25-28-21)17-11-16(22)7-8-18(17)27-3;1-13-5-3-4-10-26(13)18-8-6-14(11-17(18)23)21-24-20(25-28-21)16-12-15(22)7-9-19(16)27-2;1-13-5-3-4-10-25(13)18-9-6-14(12-22-18)20-23-19(24-27-20)16-11-15(21)7-8-17(16)26-2/h7-10,12-14,26H,4-6,11H2,1-3H3;6-9,11-12,14H,3-5,10H2,1-2H3;4-12H,1-3H3;2-10H,1H3;7-8,10-12,14H,4-6,9H2,1-3H3;6-9,11-13H,3-5,10,23H2,1-2H3;6-9,11-13H,3-5,10H2,1-2H3.

What are the key properties of 3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)aniline;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide;5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole?

3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)aniline;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide;5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole has a molecular weight of 2832.05 g/mol, XLogP of 35.16, 30 rotatable bonds, 2 hydrogen bond donors, and 41 hydrogen bond acceptors.

Where does this data come from?

All data for 3-(5-fluoro-2-methoxyphenyl)-5-[5-methyl-6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[3-methyl-4-(2-methyl-3-pyridinyl)phenyl]-1,2,4-oxadiazole;3-(5-fluoro-2-methoxyphenyl)-5-[6-(2-methylpiperidin-1-yl)-3-pyridinyl]-1,2,4-oxadiazole;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)aniline;5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)benzonitrile;N-[5-[3-(5-fluoro-2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-(2-methylpiperidin-1-yl)phenyl]methanesulfonamide;5-[4-(4-methylthiophen-3-yl)-3-(trifluoromethyl)phenyl]-3-[2-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole is sourced from PubChem (CID 159222266), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).